The measurement of cardiac markers in blood is a sensitive tool to determine a person’s risk of coronary heart disease (CHD). Trinity Biotech offers quantitative assays for the measurement of Lipoprotein (a) [Lp(a)] and also high density lipoprotein (HDL) in human serum or plasma. The levels of both proteins are associated with an increased risk of CHD.
|Product Division||Laboratory Division|
|Brand||Lab Division Brands|